Wisconsin 2025-2026 Regular Session

Wisconsin Assembly Bill AJR23 Latest Draft

Bill / Introduced Version Filed 04/15/2025

                            2025 - 2026  LEGISLATURE
LRB-1685/1
DJW:klm&wlj
2025 ASSEMBLY JOINT RESOLUTION 23
April 15, 2025 - Introduced by Representatives SUBECK, KAUFERT, BARE, BROWN, 
CLANCY, DESMIDT, EMERSON, JOERS, KITCHENS, KNODL, MADISON, 
MCCARVILLE, MELOTIK, MIRESSE, MURPHY, MURSAU, NOVAK, ORTIZ-VELEZ, 
PIWOWARCZYK, ROE, STUBBS, TRANEL, UDELL, VINING and WITTKE, 
cosponsored by Senators CABRAL-GUEVARA, CARPENTER, DRAKE, HESSELBEIN, 
L. JOHNSON, RATCLIFF, ROYS, SPREITZER, WANGGAARD and WIRCH. Referred to 
Committee on Rules. 
 
 ***AUTHORS SUBJECT TO CHANGE***
Relating to: designating April 2025 and April 2026 as Parkinson[s Disease 
Awareness Months.
Whereas, Parkinson[s disease is a chronic, progressive, neurological disease 
and is the second-most-common neurodegenerative disease in the United States; 
and
Whereas, Parkinson[s disease is estimated to affect approximately one million 
people in the United States, and the prevalence will rise to 1.2 million by 2030; and
Whereas, 90,000 people are diagnosed with Parkinson[s disease each year in 
the United States; and
Whereas, Parkinson[s disease is the 14th-leading cause of death in the United 
States, according to the Centers for Disease Control and Prevention; and
Whereas, it is estimated that the economic burden of Parkinson[s disease is at 
least $52 billion annually, including direct costs, such as treatment, and indirect 
costs, such as lost income; and
1
2
3
4
5
6
7
8
9
10
11
12
13
14 2025 - 2026  Legislature - 2 -	LRB-1685/1
DJW:klm&wlj
Whereas, research suggests the cause of Parkinson[s disease is a combination 
of genetic and environmental factors, but the exact cause of the disease is still 
unknown; and
Whereas, there is no objective test or biomarker for Parkinson[s disease, and 
there is presently no cure or drug that slows or halts the progression of the disease; 
and
Whereas, the symptoms of Parkinson[s disease vary from person to person and 
can include tremors; slowness of movement; rigidity; cognitive impairment; 
dementia; mood disorders; difficulty with balance, swallowing, chewing, and 
speaking; and a variety of other nonmotor symptoms; and
Whereas, volunteers, researchers, caregivers, and medical professionals are 
working to improve the quality of life of persons living with Parkinson[s disease and 
their families; and
Whereas, increased research, education, and community support services, 
such as those provided by the Michael J. Fox Foundation, Davis Phinney 
Foundation, Parkinson[s Foundation, Wisconsin Parkinson Association, and other 
organizations, are needed to find more effective treatments and to provide access to 
quality care to those living with the disease today; now, therefore, be it
Resolved by the assembly, the senate concurring, That April 2025 and 
April 2026 are hereby designated Parkinson[s Disease Awareness Months in 
Wisconsin.
(END)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22